期刊文献+

Preparation, characterization and release of methyl viologen from a novel nanoparticle delivery system with double shells of silica and PLGA 被引量:1

Preparation, characterization and release of methyl viologen from a novel nanoparticle delivery system with double shells of silica and PLGA
在线阅读 下载PDF
导出
摘要 The use of nanotechnology in drug delivery is a rapidly expanding field. Biodegradable or nontoxic nanomaterials have the most promising application potentials in nanomedicine. Herein, we report a novel core-shell nanoparticle with double shell coatings (silica and poly(D,L-lactide-co-glycolide) (PLGA)) with the total shell thickness of (8.7 ± 1.3) nm. The outer shell of PLGA is biodegradable and used for controlled and sustained release, and the inner shell of silica is mesoporous for the preservation of the chemical radiation therapeutic of methyl viologen (MV), an oxidant that produces reactive oxygen species during cancer radiation therapy. The dissolution time course data and transmission electron microscopy images showed that the novel nanoparticles (Au@SiO2&PLGA) have been successfully prepared, and silica and PLGA coated well the gold (Au) template surfaces. Nano- capsules (MV@SiO2&PLGA) were obtained after the gold templates were dissolved using sodium cyanide. The sustained release property was characterized through detecting fluorescence quenching time course of fluorescent isothiocyanate after mixing with MV@SiO2&PLGA nanocapsules that encapsulate MV molecules. The sustained release of MV molecules could be extended to approximately four weeks. This novel delivery system has high potential in future application for the delivery of therapeutic drugs, particularly for the treatment of cancer by radiation therapy. The use of nanotechnology in drug delivery is a rapidly expanding field. Biodegradable or nontoxic nanomaterials have the most promising application potentials in nanomedicine. Herein, we report a novel core-shell nanoparticle with double shell coatings (silica and poly(D,L-lactide-co-glycolide) (PLGA)) with the total shell thickness of (8.7 ± 1.3) nm. The outer shell of PLGA is biodegradable and used for controlled and sustained release, and the inner shell of silica is mesoporous for the preservation of the chemical radiation therapeutic of methyl viologen (MV), an oxidant that produces reactive oxygen species during cancer radiation therapy. The dissolution time course data and transmission electron microscopy images showed that the novel nanoparticles (Au@SiO2&PLGA) have been successfully prepared, and silica and PLGA coated well the gold (Au) template surfaces. Nano- capsules (MV@SiO2&PLGA) were obtained after the gold templates were dissolved using sodium cyanide. The sustained release property was characterized through detecting fluorescence quenching time course of fluorescent isothiocyanate after mixing with MV@SiO2&PLGA nanocapsules that encapsulate MV molecules. The sustained release of MV molecules could be extended to approximately four weeks. This novel delivery system has high potential in future application for the delivery of therapeutic drugs, particularly for the treatment of cancer by radiation therapy.
出处 《Chinese Science Bulletin》 SCIE EI CAS 2010年第3期263-267,共5页
基金 supported by the National Natural Science Foundation of China (Grant No. 30700151) Fujii-Otsuka International Scientific Exchange Fund from Tokushima University of Japan (Grant No.795001002b) Innovative Talent Incubation Program for Youth from University of Elec-tronic Science and Technology of China (Grant No. Y02018023601062)
关键词 二氧化硅 纳米粒子 甲基紫精 输送系统 PLGA 双壳 透射电子显微镜 可生物降解 nanoparticles, PLGA, silica, methyl viologen, drug delivery
  • 相关文献

参考文献16

  • 1Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 2003, 55: 329-347.
  • 2Cegnar M, Premzl A, Zavasnik-Bergant V, et al. Poly(lactide-coglycolide) nanoparticles as a carder system for delivering cysteine protease inhibitor cystatin into tumor cells. Exp Cell Res, 2004, 301: 223-231.
  • 3Farokhzad O C, Cheng J, Teply B A, et al. Targeted nanoparticle- aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA, 2006, 103:6315-6320.
  • 4Cheng J, Teply B A, Sheriff I, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 2007, 28:869-876.
  • 5Liu Y, Miyoshi H. Preparation and characterization of novel drug delivery system of light-sensitive silica nanocapsules with thin shells. J Biomed Nanotechnol, 2008, 4:25-32.
  • 6Luo D, Han E, Belcheva N, et al. A self-assembled, modular DNA delivery system mediated by silica nanoparticles J Control Release, 2004, 95:333 341.
  • 7Bharali D J, Klejbor I, Stachowiak E K, et al. Organically modified silica nanoparticles: a nonoviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA, 2005, 102: 11539-11544.
  • 8Lim H J, Nam H Y, Lee B H, et al. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Biotechnol Prog, 2007, 23:693-697.
  • 9Esmaeili F, Ghahremani M H, Ostad S N, et al. Folate-receptor- targeted delivery of docetaxel nanoparticles prepared by PLGA- PEG-folate conjugate. J Drug Target, 2008, 16:415423.
  • 10Anglin E J, Chen L, Freeman W R, et al. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev, 2008, 60: 1266-1277.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部